This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n5https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Robert_Kralovics
rdf:type
owl:Thing
rdfs:label
Robert Kralovics
rdfs:comment
Robert Kralovics is a Slovak born geneticist, working in the area of blood neoplasms. Robert Kralovics was born in 1970 in Nové Zámky, Slovakia, which was at that time part of Czechoslovakia. Robert Kralovics earned his master's degree in Molecular Biology and Genetics at Comenius University in Bratislava and later his PhD in Biophysics at the Academy of Sciences of the Czech Republic in Brno. He completed his post-doctoral work on the genetics of myeloproliferative disorders working with Josef Prchal at the University of Alabama in Birmingham, US. In 2000, he joined Joe Prchal’s group as assistant professor at Baylor College of Medicine in Houston. From 2001, he was a project leader with Radek Skoda in Basel, Switzerland. In 2006, Robert Kralovics joined CeMM Research Center for Molecular
dcterms:subject
dbc:Slovak_geneticists dbc:Slovak_scientists dbc:Living_people dbc:Comenius_University_alumni dbc:Year_of_birth_missing_(living_people)
dbo:wikiPageID
53336049
dbo:wikiPageRevisionID
1122702723
dbo:wikiPageWikiLink
dbr:Malignant dbr:Genetic_mutation dbc:Living_people dbr:Pathogenesis dbc:Slovak_scientists dbr:Myeloproliferative_disorder dbc:Comenius_University_alumni dbr:Myeloproliferative_neoplasms dbr:Genomics dbr:Geneticist dbr:Master's_degree dbr:Neoplasm dbr:Biophysics dbr:Research dbr:Hematological dbr:Comenius_University dbr:Immunotherapy dbr:Bratislava dbc:Year_of_birth_missing_(living_people) dbr:Blood dbr:JAK2_kinase_gene dbr:Myeloid_malignancies dbr:Lieben_Prize dbc:Slovak_geneticists
owl:sameAs
wikidata:Q29887665 n5:2mcEy yago-res:Robert_Kralovics
dbp:wikiPageUsesTemplate
dbt:Slovakia-bio-stub dbt:Reflist dbt:Geneticist-stub dbt:One_source dbt:Authority_control dbt:Third-party dbt:Multiple_issues
dbo:abstract
Robert Kralovics is a Slovak born geneticist, working in the area of blood neoplasms. Robert Kralovics was born in 1970 in Nové Zámky, Slovakia, which was at that time part of Czechoslovakia. Robert Kralovics earned his master's degree in Molecular Biology and Genetics at Comenius University in Bratislava and later his PhD in Biophysics at the Academy of Sciences of the Czech Republic in Brno. He completed his post-doctoral work on the genetics of myeloproliferative disorders working with Josef Prchal at the University of Alabama in Birmingham, US. In 2000, he joined Joe Prchal’s group as assistant professor at Baylor College of Medicine in Houston. From 2001, he was a project leader with Radek Skoda in Basel, Switzerland. In 2006, Robert Kralovics joined CeMM Research Center for Molecular Medicine in Vienna, Austria as an independent principal investigator. His research interests lie primarily in myeloproliferative neoplasms (MPNs) and in in general. His major achievements so far include the identification of mutations in the (V617F) and the identification of CALR gene mutations, which play an important role in MPN pathogenesis. Robert Kralovics continues his research at CeMM seeking to find new mutations causing familial predisposition to hematological malignancies using advanced genomics approaches and understanding how genetic variability contributes to the disease. More recently, Robert’s research focuses on the development of immunotherapy for CALR-positive patients and the identification of novel therapeutic strategies in MPNs. In 2010, Robert Kralovics was awarded with the Lieben Prize of the Austrian Academy of Sciences for achievements in uncovering the genetic basis of myeloproliferative disorders.
prov:wasDerivedFrom
wikipedia-en:Robert_Kralovics?oldid=1122702723&ns=0
dbo:wikiPageLength
2592
foaf:isPrimaryTopicOf
wikipedia-en:Robert_Kralovics